Meet the Innovators Behind AGA Nanotech

Founded in 2014, AGA Nanotech aims to preserve antibiotics, protect patients and prevent resistance, with our innovative antimicrobial delivery system, Battlestar™ . Our team members are the visionaries behind Gama Healthcare, a leading infection prevention and control company.

In Gama we developed the Clinell, Carell, and Hexi range of cleaning, disinfecting and antiseptic products and commercialised a range of precursor-generated peracetic acid products, including the first precursor-generated peracetic acid wipe, which is clinically proven to reduce C. difficile infections by 72% and decrease the spread of multidrug-resistant organisms (MDRO) in a double cross-over study.

Harsha Siani

CEO

Harsha Siani graduated from the University of Hertfordshire and Cardiff University in Microbiology and Pharmaceutical Microbiology. She has extensive experience in commercial business development and regulatory science, having worked at the MHRA before returning to Gama Healthcare as both commercial and technical director.

Leah Conway

Principle Scientist

Leah Conway specializes in pioneering technologies to fight antimicrobial resistance. Her leadership in developing complex product formulations underscores her innovative approach to science. Leah’s contributions as an inventor and author highlight her commitment to advancing the field of antimicrobial resistance both scientifically and commercially.

Adrian Fellows

Founder and Inventor

Adrian Fellows has successfully led the R&D and commercial development of a wide variety of infection control products and interventions from the 1980s to the present day. An experienced microbiologist and chemist, Adrian is an inventor of several patents and a published author.

Guy Braverman

Founder

Dr. Guy Braverman graduated from the Royal Free and University College Medical School in 2003. A recognized entrepreneur, Guy is committed to supporting advances in infection prevention to save and improve lives.

Allen Hanouka

Founder

Dr. Allen Hanouka graduated from Manchester Medical School in 1998. His passion for science and drive for commercial success have contributed to Gama Healthcare being a trusted IPC partner in hospitals globally.

Our Facilities

AGA Nanotech operates from shared office space in the Maylands Building and has a dedicated R&D space in Halifax, UK to support Battlestar production, analytical assessment and formulation science.

Our Mission

AGA Nanotech is committed to fostering collaborative partnerships with investors, funders, academic and clinical partners, and those interested in acquiring our technology. Our team’s extensive technical, clinical, and commercial experience makes us a trusted partner in the fight against antimicrobial resistance.